555 related articles for article (PubMed ID: 16876996)
1. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
Livermore DM; Woodford N
Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
3. Rapid characterization of beta-lactamases by multiplex PCR.
Woodford N
Methods Mol Biol; 2010; 642():181-92. PubMed ID: 20401595
[TBL] [Abstract][Full Text] [Related]
4. Genotypic analysis of plasmid-mediated beta-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin.
Kiratisin P; Henprasert A
Int J Antimicrob Agents; 2010 Oct; 36(4):343-7. PubMed ID: 20688485
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.
Shahid M; Sobia F; Singh A; Malik A; Khan HM; Jonas D; Hawkey PM
Crit Rev Microbiol; 2009; 35(2):81-108. PubMed ID: 19514910
[TBL] [Abstract][Full Text] [Related]
6. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
7. Multiresistant Enterobacteriaceae: new threat of an old problem.
Pitout JD
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
[TBL] [Abstract][Full Text] [Related]
9. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
[TBL] [Abstract][Full Text] [Related]
10. Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals.
Celenza G; Pellegrini C; Caccamo M; Segatore B; Amicosante G; Perilli M
J Antimicrob Chemother; 2006 May; 57(5):975-8. PubMed ID: 16510850
[TBL] [Abstract][Full Text] [Related]
11. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
Mushtaq S; Ge Y; Livermore DM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1313-9. PubMed ID: 15047535
[TBL] [Abstract][Full Text] [Related]
12. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae.
Bush K
Curr Opin Microbiol; 2010 Oct; 13(5):558-64. PubMed ID: 20920882
[TBL] [Abstract][Full Text] [Related]
13. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].
Martínez-Martínez L; Calvo J
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():25-31. PubMed ID: 21130927
[TBL] [Abstract][Full Text] [Related]
14. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
Bedenić B
Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
[TBL] [Abstract][Full Text] [Related]
15. The spread of CTX-M-type extended-spectrum beta-lactamases.
Rossolini GM; D'Andrea MM; Mugnaioli C
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():33-41. PubMed ID: 18154526
[TBL] [Abstract][Full Text] [Related]
16. [KPC carbapenemases: what is at stake in clinical microbiology?].
Cuzon G; Naas T; Nordmann P
Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
18. [Carbapenemases in Pseudomonas spp].
Juan Nicolau C; Oliver A
Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():19-28. PubMed ID: 20172419
[TBL] [Abstract][Full Text] [Related]
19. Clinically significant carbapenemases: an update.
Walsh TR
Curr Opin Infect Dis; 2008 Aug; 21(4):367-71. PubMed ID: 18594288
[TBL] [Abstract][Full Text] [Related]
20. Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
Lee K; Ha GY; Shin BM; Kim JJ; Kang JO; Jang SJ; Yong D; Chong Y;
Diagn Microbiol Infect Dis; 2004 Sep; 50(1):51-8. PubMed ID: 15380278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
